ME Therapeutics Holdings, Inc. provides biotechnology and pharmaceutical services. It engages in research and development of cancer fighting drugs in the field of immuno-oncology (IO). ME Therapeutics Holdings develops drug candidates that can increase the efficacy of current IO drugs by targeting suppressive myeloid cells which are known to hinder the effectiveness of current IO treatments. The company was founded on November 9, 2021 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of ME Therapeutics Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. ME Therapeutics Holdings Inc market cap is $87.21M.
What is the 52-week high for ME Therapeutics Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. ME Therapeutics Holdings Inc 52 week high is $2.95 as of October 01, 2025.
What is the 52-week low for ME Therapeutics Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. ME Therapeutics Holdings Inc 52 week low is $2.95 as of October 01, 2025.
What is ME Therapeutics Holdings Inc stock price today?
ME Therapeutics Holdings Inc stock price today is $2.95.
What is the PE ratio of ME Therapeutics Holdings Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. ME Therapeutics Holdings Inc’s P/E ratio is -93.87.
What is the Price-to-Book ratio of ME Therapeutics Holdings Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. ME Therapeutics Holdings Inc P/B ratio is 65.1215.
What is the 50-day moving average of ME Therapeutics Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. ME Therapeutics Holdings Inc 50-day moving average is $2.95.